ReviewBone marrow transplantation2021

HSCT remains the only cure for patients with transfusion-dependent thalassemia until gene therapy strategies are proven to be safe.

Christina Oikonomopoulou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.